Zeile 105: |
Zeile 105: |
| Kaske: | | Kaske: |
| Genau. | | Genau. |
− | ---------------------------------------------- | + | |
| + | ==Weitere Auftragsstudien zu Regividerm== |
| + | Dosefinding Study |
| + | conducted in UK by Dr. Parnham of |
| + | FIRE CRO, Bonn (Germany) |
| + | randomised double-blind study with |
| + | n=29 (atopic dermatitis) |
| + | n=28 (psoriasis) |
| + | 1998 |
| + | |
| + | Local Tolerability Study |
| + | conducted by Dr. Theodor of |
| + | PHAROS CRO, Ulm (Germany) |
| + | randomised double-blind study with |
| + | n=40 healthy volunteers |
| + | 2001 |
| + | |
| + | Explorative Phase II Clinical Trial on |
| + | the Efficacy and Tolerability of |
| + | Regividerm in Atopic Dermatitis |
| + | conducted by Dr. Schulze of |
| + | Hornheide Specialist Clinic, |
| + | University of Muenster, (Germany) |
| + | randomised, double-blind and |
| + | placebo-controlled monocentre study |
| + | with n=20 patients in intraindividual |
| + | left/right side comparison |
| + | 2001 |
| + | |
| + | Regividerm in Psoriasis |
| + | conducted by Dr. Schulze of |
| + | Hornheide Specialist Clinic, |
| + | University of Muenster, (Germany) |
| + | randomised, double-blind and |
| + | placebo-controlled monocentre study |
| + | with n=21 patients in intraindividual |
| + | left/right side comparison |
| + | 2002 |
| + | |
| + | Explorative Phase II Clinical Trial on the Efficacy |
| + | and Tolerability of Regividerm in Psoriasis |
| + | in Comparison to Calcipotriol 1 |
| + | conducted by Prof. Altmeyer of |
| + | St. Josef Hospital, |
| + | University of Bochum, (Germany) |
| + | randomised, reference-drug-controlled |
| + | monocentre study with n=15 patients |
| + | in intraindividual left/right side comparison |
| + | |
| + | Explorative Phase II Clinical Trial on the Efficacy |
| + | and Tolerability of Regividerm in Psoriasis |
| + | in Comparison to Calcipotriol 1 |
| + | conducted by Prof. Altmeyer of |
| + | St. Josef Hospital, |
| + | University of Bochum, (Germany) |
| + | randomised, reference-drug-controlled |
| + | monocentre study with n=15 patients |
| + | in intraindividual left/right side comparison |
| + | |
| + | Confirmative Phase III Clinical Trial on |
| + | the Efficacy and Tolerability of |
| + | Regividerm in Atopic Dermatitis |
| + | conducted by Prof. Niedner (principal |
| + | investigator) of Ernst von Bergmann Clinic, |
| + | University (FU) of Berlin, (Germany) |
| + | and Prof. Altmeyer of St. Josef Hospital, |
| + | University of Bochum, (Germany) |
| + | randomised, double-blind and |
| + | placebo-controlled multicentre study |
| + | with n=47 patients in intraindividual |
| + | left/right side comparison |
| + | |
| + | Confirmative Phase III Clinical Trial on |
| + | the Efficacy and Tolerability of |
| + | Regividerm in Psoriasis |
| + | conducted by Prof. Altmeyer (principal |
| + | investigator) of St. Josef Hospital, |
| + | University of Bochum, (Germany) and |
| + | Prof. Niedner of Ernst von Bergmann Clinic, |
| + | University (FU) of Berlin, (Germany) |
| + | randomised, double-blind and |
| + | placebo-controlled multicentre study |
| + | with n=51 patients in intraindividual |
| + | left/right side comparison. |